https://seer.cancer.gov/statfacts/html/breast.html - last accessed 8th November 2023.
Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, et al. A population-based study of genes previously implicated in breast cancer. N Engl J Med. 2021;384(5):440–51.
Article PubMed PubMed Central Google Scholar
Stefansdottir V, Thorolfsdottir E, Hognason HB, et al. Web-based return of BRCA2 research results: one-year genetic counselling experience in Iceland. Eur J Hum Genet. 2020;28(12):1656–61.
Article PubMed PubMed Central Google Scholar
Rowley SM, Mascarenhas L, Devereux L, et al. Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility. Genet Med. 2019;21(4):913–22.
Article PubMed CAS Google Scholar
Manickam K, Buchanan AH, Schwartz MLB, et al. Exome sequencingbased screening for BRCA1/2 expected pathogenic variants among adult biobank participants. JAMA Netw Open. 2018;1(5): 182140.
Wong-Brown MW, Meldrum CJ, Carpenter JE, et al. Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. Breast Cancer Res Treat. 2015;150:71–80.
Article PubMed CAS Google Scholar
Peshkin BN, Alabek ML, Isaacs C. BRCA1/2 mutations and triple negative breast cancers. Breast Dis. 2010;32:25–33.
Henderson V, Madrigal JM, Kendall LC, et al. Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk. BMC Health Serv Res. 2022;22(1):826.
Article PubMed PubMed Central Google Scholar
Murray MF, Evans JP, Angrist M et al. (2022) A proposed approach for implementing genomics-based screening programs for healthy adults. NAM Perspect https://doi.org/10.31478/201812a.
Reblin M, Kasting ML, Nam K, Scherr CL et al. Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors. Breast J 2019;117–123.
Blondeaux E, Lambertini M, Buzzatti G, et al. Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result. J Genet Couns. 2023;32(1):140–52.
Pujol P, Barberis M, Beer P, et al. Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. Eur J Cancer. 2021;146:30–47.
Article PubMed CAS Google Scholar
NCCN Guidelines. https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf (last updated september 27, 2023).
Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021;7(2):230–7.
Kurian AW, Li Y, Hamilton AS, et al. Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol. 2017;35(20):2232–9.
Article PubMed PubMed Central Google Scholar
Ruddy KJ, Risendal BC, Garber JE, Partridge AH. Cancer survivorship care: an opportunity to revisit cancer genetics. J Clin Oncol. 2016;34(6):539–41.
Article PubMed CAS Google Scholar
Mandelker D, Zhang L, Kemel Y, et al. Mutation detection in patients with advanced cancer by universal sequencing of cancerrelated genes in tumor and normal DNA vs guideline-based germline testing. JAMA. 2017;318(9):825–35.
Article PubMed PubMed Central Google Scholar
Turbitt E, Roberts MC, Taber JM, et al. Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: results from the 2015 National Health Interview Survey. Prev Med. 2019;123:12–9.
Article PubMed PubMed Central Google Scholar
Vadaparampil ST, Quinn GP, Miree CA, et al. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients. Ann Surg Oncol. 2009;16:1973–81.
Vadaparampil ST, Malo TL, Nam KM, et al. From observation to intervention: development of a psychoeducational intervention to increase uptake of BRCA genetic counseling among high-risk breast cancer survivors. J Cancer Educ. 2014;29:709–19.
Article PubMed PubMed Central Google Scholar
Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-associated hereditary breast and ovarian cancer 1998; [updated 2016 Dec 15]. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds) GeneReviews® [internet]. University of Washington, Seattle; 1993–2021.
Childers CP, Childers KK, Maggard-Gibbons M, Macinko J. National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol. 2017;35:3800–6.
Article PubMed PubMed Central Google Scholar
Armstrong J, Toscano M, Kotchko N, et al. Utilization and outcomes of BRCA genetic testing and counseling in a national commercially insured population: the ABOUT Study. JAMA Oncol. 2015;1:1251–60.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1–9.
Hong QN, Gonzalez-Reyes A, Pluye P. Improving the usefulness of a tool for appraising the quality of qualitative, quantitative and mixed methods studies, the Mixed Methods Appraisal Tool (MMAT). J Eval Clin Pract. 2018;24(3):459–67.
Park JS, Shin S, Lee YJ, et al. Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer. Cancer Res Treat. 2022;54(4):1099–110.
Article PubMed CAS Google Scholar
Tran AT, Hwang JH, Choi E, et al. Impact of awareness of breast density on perceived risk, worry, and intentions for future breast cancer screening among Korean women. Cancer Res Treat. 2021;53:55–64.
Kritzik R, Usoro E, Peshkin BN, et al. Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosis. Psychooncology. 2022;31(5):788–97.
Armstrong J, Lynch K, Virgo KS, et al. Utilization, Timing, and Outcomes of BRCA Genetic Testing Among Women With Newly Diagnosed Breast Cancer From a National Commercially Insured Population: The ABOARD Study. JCO Oncol Pract. 2021;17(2):226–35.
Wevers MR, Aaronson NK, Verhoef S, et al. Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial. Br J Cancer. 2014;110(4):1081–7.
Article PubMed PubMed Central CAS Google Scholar
Clarijs ME, van Egdom LSE, Verhoef C, Vasilic D, Koppert LB, PROFAS Collaborator Group. Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS). BMJ Open. 2023;13(2):066728.
Schwartz MD, Peshkin BN, Isaacs C, et al. Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients. Breast Cancer Res Treat. 2018;170(3):517–24.
Article PubMed PubMed Central Google Scholar
Wevers MR, Ausems MG, Verhoef S, et al. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial. BMC Cancer. 2011;11:6.
Article PubMed PubMed Central Google Scholar
Chapman-Davis E, Zhou ZN, Fields JC, et al. Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center. J Gen Intern Med. 2021;36(1):35–42.
Simon MS, Petrucelli N. Hereditary breast and ovarian cancer syndrome : the impact of race on uptake of genetic counseling and testing. Methods Mol Biol. 2009;471:487–500.
Wehbe A, Manning M, Assad H, Purrington KS, Simon MS. Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer. Cancer Med. 2022;11(17):3304–11.
Article PubMed PubMed Central Google Scholar
Cragun D, Bonner D, Kim J, et al. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Breast Cancer Res Treat. 2015;151(1):169–76.
留言 (0)